<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiac <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is a metabolic and functional disorder that is often associated with <z:hpo ids='HP_0001513'>obesity</z:hpo> and/or the cardiorenal <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e>), and this disorder may be accentuated by <z:hpo ids='HP_0011010'>chronic</z:hpo> alcohol consumption </plain></SENT>
<SENT sid="1" pm="."><plain>In conditions of over-nutrition, increased insulin (INS) and <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> (<z:chebi fb="0" ids="48432">Ang II</z:chebi>) activate mammalian target for <z:chebi fb="0" ids="9168">rapamycin</z:chebi> (mTOR)/p70 S6 kinase (S6K1) signaling, whereas <z:hpo ids='HP_0011010'>chronic</z:hpo> alcohol consumption inhibits mTOR/S6K1 activation in cardiac tissue </plain></SENT>
<SENT sid="2" pm="."><plain>Although excessive activation of mTOR/S6K1 induces cardiac INS resistance via serine phosphorylation of INS receptor substrates (IRS-1/2), it also renders cardioprotection via increased <z:chebi fb="0" ids="48432">Ang II</z:chebi> receptor 2 (AT2R) upregulation and adaptive <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In the INS-resistant and hyperinsulinemic <z:chebi fb="3" ids="16646">Zucker</z:chebi> <z:mp ids='MP_0001261'>obese</z:mp> (ZO) rat, a <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent model</z:e> for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e>, activation of mTOR/S6K1signaling in cardiac tissue is regulated by protective feed-back mechanisms involving mTORâ†”AT2R signaling loop and profile changes of microRNA that target S6K1 </plain></SENT>
<SENT sid="4" pm="."><plain>Such regulation may play a role in attenuating progressive <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Conversely, alcohol-mediated inhibition of mTOR/S6K1, down-regulation of INS receptor and growth-inhibitory mir-200 family, and upregulation of mir-212 that promotes fetal gene program may exacerbate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e>-related <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>